Should You Buy Nomura Holdings Inc Stock in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Nomura Holdings Inc (NMR) is rated as a strong fundamental performer with a QOC score of 7.6/10. Trading at $9.82, our valuation engine evaluates whether the market price reflects the company's underlying earnings power.
The short answer: 9 of 9 CirclFi valuation models project upside for Nomura Holdings Inc (NMR) at $9.82 — the model consensus leans bullish, with a Quality Score of 7.6/10 and Value-Trap risk of 18/100. The full bull case, bear case, and risk factors are below. Educational analysis, not financial advice.
Investment Thesis
The Bull Case
Target: $40.28 (+310.2% upside)
- According to the CirclFi Quality of Company (QOC) framework, Nomura Holdings Inc's rating of 7.6/10 signals strong fundamentals — high-quality businesses tend to compound value more reliably.
- According to the CirclFi Deep Alpha Valuation Engine, 6 of 9 models identify upside from $9.82 to a composite fair value of $19.95, indicating the market hasn't fully priced in Nomura Holdings Inc's earnings power.
- According to the CirclFi Deep Alpha Valuation Engine, the Earnings Power Value (EPV) model targets a fair value of $40.28 (+310.2%), anchoring the bull case with a methodology that strips out growth assumptions to value sustainable earnings alone.
The Bear Case
No active models currently flag significant downside for NMR. The low Value Trap score paints a constructive picture.
The Bottom Line
The balance of evidence tilts cautiously positive for Nomura Holdings Inc at $9.82. 6 of 9 models support upside to $19.95, backed by a 7.6/10 quality foundation. This is a "lean into, not load up on" setup in our framework.
These are quantitative model outputs, not investment recommendations. Nomura Holdings Inc's future depends on factors — management execution, competitive dynamics, regulatory changes — that no algorithm can fully capture. See all 13 model estimates →
Frequently Asked Questions
Should I buy NMR stock right now?
Based on CirclFi's multi-model analysis, 9 of 9 models see upside for NMR at $9.82. The majority of models suggest the stock trades below fair value, but investors should weigh this against the Quality Score of 7.6/10 and individual risk tolerance. This is not a buy recommendation — see our full disclaimer.
What are the biggest risks of investing in Nomura Holdings Inc?
Key risks include: wide model disagreement (308% spread), signaling high uncertainty; general market and sector-specific risks affecting Security Brokers, Dealers & Flotation Companies companies. Always diversify and consult a financial advisor.
How does NMR compare to its competitors?
Among Security Brokers, Dealers & Flotation Companies peers, NMR holds a Quality Score of 7.6/10. Comparable companies include FUTU (QOC 10.0), SIEB (QOC 9.7), BLK (QOC 9.7). The relative ranking helps investors identify whether NMR offers better fundamental quality than alternatives in the same sector.
Is NMR a good long-term investment?
Long-term investment potential depends on fundamental quality and sustainable competitive advantages. NMR's Quality Score of 7.6/10 is encouraging for long-term holders, indicating consistent profitability, manageable debt, and healthy cash flows. Check our full data page for all 13 model estimates.
What price should I buy NMR at?
CirclFi does not provide target buy prices or price alerts. However, our 9 active models produce fair value estimates ranging from $9.88 to $40.28. At $9.82, the stock trades below even the most conservative estimate, which may represent a margin of safety — or reflect risks the models don't capture. Many value investors look for a 20-30% margin of safety below intrinsic value before buying.
Want the complete picture?
See all 13 model estimates, confidence scores, and the full valuation table for NMR.
Disclaimer: This article is produced by the CirclFi Valuation Engine using quantitative models and is for educational and informational purposes only. It is not financial advice, a buy/sell recommendation, or a solicitation to trade securities. Past performance is not indicative of future results. All data sourced from SEC EDGAR, FRED, and GDELT. Consult a licensed financial advisor before making investment decisions. Full disclaimer →